Saturna Capital Corp’s Abbott Laboratories Position
Does Saturna Capital Corp own Abbott Laboratories (ABT)? Yes — 391.9K shares worth $40M (+0.56% of its 13F portfolio) as of Q1 2026, up from 391.9K shares the prior filed quarter.
Position Value
$40M
Q1 2026
Shares
391.9K
% of Portfolio
+0.56%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 391.9K | $40M | +0.56% |
| Q4 2025 | 391.9K | $49M | +0.65% |
| Q3 2025 | 392.3K | $53M | +0.68% |
| Q2 2025 | 392.4K | $53M | +0.72% |
| Q1 2025 | 393.3K | $52M | +0.78% |
| Q4 2024 | 394.2K | $45M | +0.60% |
| Q3 2024 | 394.1K | $45M | +0.59% |
| Q2 2024 | 407.1K | $42M | +0.56% |
| Q1 2024 | 424.1K | $48M | +0.67% |
| Q4 2023 | 426.9K | $47M | +0.73% |
| Q3 2023 | 432.7K | $42M | +0.74% |
| Q2 2023 | 436.6K | $48M | +0.82% |
| Q1 2023 | 433.7K | $44M | +0.85% |
| Q4 2022 | 432.8K | $48M | +1.02% |
| Q3 2022 | 438.2K | $42M | +1.03% |
| Q2 2022 | 438.5K | $48M | +1.13% |
| Q1 2022 | 439.2K | $52M | +1.05% |
| Q4 2021 | 437.2K | $60M | +1.07% |
| Q3 2021 | 437.0K | $52M | +1.04% |
| Q2 2021 | 434.7K | $50M | +1.03% |
| Q1 2021 | 432.8K | $52M | +1.16% |
| Q4 2020 | 429.6K | $47M | +1.19% |
| Q3 2020 | 429.6K | $47M | +1.23% |
| Q2 2020 | 429.1K | $39M | +1.10% |
| Q1 2020 | 429.1K | $34M | +1.10% |
| Q4 2019 | 429.0K | $37M | +1.01% |
| Q3 2019 | 429.0K | $36M | +1.04% |
| Q2 2019 | 429.3K | $36M | +1.06% |
| Q1 2019 | 429.1K | $34M | +1.00% |
| Q4 2018 | 433.7K | $31M | +1.06% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Saturna Capital Corp’s full portfolio or all institutional holders of ABT.